MedPath

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Not Applicable
Conditions
Papillary Thyroid Cancer
Registration Number
NCT00984191
Lead Sponsor
Chulalongkorn University
Brief Summary

The purpose of this trial is to see if the 99mTechnetium-MIBI SPECT-CT can be a tool for preoperative evaluation of cervical node metastasis in papillary thyroid cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • papillary thyroid cancer
Exclusion Criteria
  • pregnancy
  • Bleeding abnormality
  • Prior history of head and neck cancer
  • can not perform 99mTechnetium-MIBI SPECT-CT
  • can not perform 131I remnant Ablation
  • Prior any head and neck surgery within 3 months
  • Prior deep neck infection within 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )18 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

King Chulalongkorn Hospital

🇹🇭

Pathumwan, Bangkok, Thailand

King Chulalongkorn Hospital
🇹🇭Pathumwan, Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.